
Sarcoma and HCC Oncologist at IU Simon Cancer Center. Half of @TwoOncDocs podcast. All Tweets are my own.
Joined June 2019
- Tweets178
- Following226
- Followers696
- Likes496
Samantha Armstrong retweeted
🧬Combination ICI outcomes in heavily pretreated advanced sarcoma: although many patients had rapid progression, durable responses were seen in carefully selected patients, including those with ultra-rare histologies. @susanebates @gbanna74 @PasRescigno doi.org/10.1093/oncolo/oyag3…
Samantha Armstrong retweeted
🤔 Headed to #ASH26? Join for a FREE board review!
🗓️ In-person w/@OncBrothers + @TwoOncDocs
📅 Friday, December 11, 2026
📍 Common House, New Orleans
🔗 Register: bit.ly/hemeboards
👉 Tag someone studying for boards
@ASH_hematology #OncTwitter #HemOnc #MedX #MedTwitter
Samantha Armstrong retweeted
🤔 Heading to #ASH26?
⭐️ Join us for a complimentary in-person Hematology Board Review for fellows & anyone prepping for boards 🩸
📅 Friday, December 11, 2026
🕗 8:00 AM–12:00 PM CT
📍 420 Julia St., New Orleans, LA
🔗 Register: bit.ly/hemeboards
🤖 Made with AI
Samantha Armstrong retweeted
Our newest episode out today with @doclauravater on the transition from fellow to attending & mistakes she made as a new attending physician (so you don’t have to)
It really hit home for a lot of us, with tips on managing each of these 🫶🏼
podcasts.apple.com/us/podcas…
Samantha Armstrong retweeted
Samantha Armstrong retweeted
More @ASCO news coverage of the SARC041 study of abemaciclib versus placebo in DDLPS. Median PFS of 9.7 months vs. 1.5 months. The efficacy of abemaciclib looks remarkable and we are looking forward to future studies in #liposarcoma #asco26 #sarcoma
Samantha Armstrong retweeted
Standing ovation for a ***breakthrough*** in #pancreaticcancer 🥹🥹🥹
#RASolute today presented at #ASCO26:
Daraxonrasib DOUBLES the median overall survival in metastatic pancreatic cancer w/ +w/o RAS (mOS 13.2 mo vs. 6.6 mo)
A HUGE advance in one of the most lethal cancers 💜 – at Chicago, IL
Samantha Armstrong retweeted
🤩SARCOMA AT PLENARY!🎗️
🔹 SARC041 provides the first randomized validation of CDK4 inhibition in DDLPS
📈 mPFS: 9.7 vs 1.5 mo (HR 0.39, p<0.001) — >6× improvement
🎯 ORR: 9.3% vs 0%
⏳ OS trend favors abemaciclib (HR 0.55)
🔄 Crossover activity confirmed (mPFS 3.4 mo)
#ASCO26
Samantha Armstrong retweeted
My fav ASCO D2 highlight so far. Cheesing because we met half of @TwoOncDocs @ASCO @asco2026 – at Chicago, IL
Samantha Armstrong retweeted
PODCAST-HOF trial featuring @TheFellowOnCall and @TwoOncDocs and published in @JCO_ASCO-OP being highlighted as one of the biggest med ed research studies of the past year to know at the #ASCO26 Medical Education Committee on Practice event! 🎉
The most inspirational part of the @SARCtrials semiannual meeting was hearing AYA OST survivors share their stories and hopes for the future.
Thank you to @AgentsMIB for amplifying their voices and inspiring us all.
Advocacy leads to policy change 🎗️
1
160
Samantha Armstrong retweeted
Huge THANK YOU to everyone who joined our “Clinicals to Exam” board review session! 📚🔥🎙️
Nothing beats meeting fellow learners IRL 🫶
Shoutout to our incredible co-hosts @OncBrothers and amazing panelists @JenSchwartzIUSM and Dr. Carlos Doti 👏✨
Now…who’s ready for #ASCO26
Samantha Armstrong retweeted
1 day until Clinicals to Exam 🌟 pre #ASCO26
From 1-5PM, we will cover a high yield overview of:
Board Prep 101
Breast CA
Lung CA
CRC
Pancreatic CA
Testicular CA
Prostate CA
Genetics & Biomarkers
& new this year a special panel Life After Fellowship inc @JenSchwartzIUSM
Samantha Armstrong retweeted
🌟3🌟 part Pancreatic Cancer updates with our very special guest @MPishvaian from @TumorBoardTues 💜
Part 1: risk factors, germline & somatic testing, diagnosis & localized tx - out this week!
Part 2: tx paradigm for metastatic pancreatic CA
Part 3: supportive care & trials
Samantha Armstrong retweeted
We did a new topic this week!
Rad Onc 101 with @RadOncTalks ☢️
In part 1, we reviewed types of RT, how it works, the patient experience & common AEs
In part 2 we will review duration & fractionation schemes, indications for RT & more
@HemOncFellows
Samantha Armstrong retweeted
CONGRATS to all of those who matched into the best speciality this past week!!
& congrats to all who found out they passed their Onc Boards today, we love hearing from you ❤️
We are back this week with updates on GISTs & next week from #ASH25
podcasts.apple.com/us/podcas…
Samantha Armstrong retweeted
Thank you @TwoOncDocs for the amazing podcast — learning so much from every episode!
#oncolo






























